Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy

Overactivation of mineralocorticoid receptor pathways has been implicated in the pathophysiology of central serous chorioretinopathy (CSCR). Recently, mineralocorticoid receptor antagonists such as eplerenone have demonstrated success in treating subretinal fluid in CSCR. This case demonstrates a pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Kapil G., Wagner, Alan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: December, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777938/
https://www.ncbi.nlm.nih.gov/pubmed/26955352
http://dx.doi.org/10.1159/000442661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777938/
https://www.ncbi.nlm.nih.gov/pubmed/26955352
http://dx.doi.org/10.1159/000442661

Ejemplares similares